Found 168 matching trials
Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
PHASE2The trial is a single-centre, randomized, double-blind, parallel trial in G...
Location
Profil Institut für Stoffwechselforschung GmbH
Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2
PHASE2In previous studies, investigators have studied if a pre-meal insulin bolus...
Location
Institut de recherches cliniques de Montréal
A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight
PHASE1The primary objective is to evaluate the safety and tolerability of VRB-103...
Incretin-based Therapy in Late Preclinical Type 1 Diabetes
PHASE2The objective of the trial is to study whether daily treatment with liraglu...
Location
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
PHASE1This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Location
Profil Institut für Stoffwechselforschung GmbH
Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
PHASE4The purpose of this research study is to learn about the effect of Liraglut...
Location
Multiple Locations
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
NANormalizing weight gain and preventing the redistribution of body fat is a ...
Location
CHU de Nice - Hôpital de l'Archet
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
PHASE2The trial is a single-centre, randomised, sequential, cross-over trial asse...
Location
Profil Institut für Stoffwechselforschung GmbH
LIPT - Liraglutide in Polycystic Ovary Syndrome
PHASE4Polycystic ovary syndrome (PCOS) affects 5-10% of women in fertile age. PCO...
Location
Dept. of Medicine and Dept. of Gyn-Obs, Herlev Hospital